ALS: Amyotrophic Lateral Sclerosis
May 4, 2017
ALS: Behind The Mystery
ALS is a rare, debilitating neurodegenerative disease that can affect anyone. We’ll meet a man who has been diagnosed with ALS and faces daily challenges associated with the rare disease. We’ll also hear from Dr. Steven Perrin, CEO and Chief Scientific Officer at the ALS Therapy Development Institute in Cambridge, Mass., who will explain the latest research in their dedicated efforts to seek a cure. It’s part of the Mystery Behind the Rare Disease series on the Balancing Act.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.